389 related articles for article (PubMed ID: 768760)
21. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
[TBL] [Abstract][Full Text] [Related]
22. Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens.
Baker CJ; Kasper DL; Edwards MS; Schiffman G
N Engl J Med; 1980 Jul; 303(4):173-8. PubMed ID: 6155612
[TBL] [Abstract][Full Text] [Related]
23. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
24. [Antibodies to group B streptococci in maternal and cord sera].
Kubota T; Takada M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):676-82. PubMed ID: 2527933
[TBL] [Abstract][Full Text] [Related]
25. Prevention of neonatal group B streptococcal infections: advances in maternal vaccine development.
Coleman RT; Sherer DM; Maniscalco WM
Obstet Gynecol; 1992 Aug; 80(2):301-9. PubMed ID: 1635750
[TBL] [Abstract][Full Text] [Related]
26. Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III group B streptococcal infection.
Heiman HS; Weisman LE
Pediatr Res; 1989 Dec; 26(6):629-32. PubMed ID: 2689988
[TBL] [Abstract][Full Text] [Related]
27. Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.
Hastings MJ; Neil J; Easmon CS
Br J Exp Pathol; 1985 Jun; 66(3):317-23. PubMed ID: 3890914
[TBL] [Abstract][Full Text] [Related]
28. Group B streptococcal vaccines.
Baker CJ; Kasper DL
Rev Infect Dis; 1985; 7(4):458-67. PubMed ID: 3898306
[TBL] [Abstract][Full Text] [Related]
29. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
Madoff LC; Paoletti LC; Tai JY; Kasper DL
J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
[TBL] [Abstract][Full Text] [Related]
30. Intraamniotic infection due to group G streptococcus: treatment and antibody response.
Larsen JW; London WT; Baker CJ; Curfman BL; Sever JL
Obstet Gynecol; 1981 Aug; 58(2):222-6. PubMed ID: 7019795
[TBL] [Abstract][Full Text] [Related]
31. The detection of streptococcal antigens using monoclonal antibodies.
Harris MC; Polin RA
Clin Lab Med; 1985 Sep; 5(3):545-60. PubMed ID: 3899481
[TBL] [Abstract][Full Text] [Related]
32. Maternal ABO blood group type B: a risk factor in the developement of neonatal group B streptococcal disease.
Regan JA; Chao S; James LS
Pediatrics; 1978 Oct; 62(4):504-9. PubMed ID: 362365
[TBL] [Abstract][Full Text] [Related]
33. [Study of carrier rate and immunity to group B streptococcus (GBS) in unmarried women].
Sugiyama A; Shiraki N; Sugiyama M; Nishiyama Y
Nihon Koshu Eisei Zasshi; 1991 Feb; 38(2):106-11. PubMed ID: 1932783
[TBL] [Abstract][Full Text] [Related]
34. Immunodeterminant specificity of human immunity to type III group B streptococcus.
Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
[TBL] [Abstract][Full Text] [Related]
35. Antibody levels in mothers colonised with group B streptococci during pregnancy and in their newborn infants, as measured by an enzyme linked immunosorbent assay.
Cleat PH; Ross J; Needham JR
Med Microbiol Immunol; 1980 Feb; 168(1):49-53. PubMed ID: 6991897
[TBL] [Abstract][Full Text] [Related]
36. Editorial: The perinatal group B streptococcal problem: more questions than answers.
Feigin RD
N Engl J Med; 1976 Jan; 294(2):106-7. PubMed ID: 1105184
[No Abstract] [Full Text] [Related]
37. Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay.
Edwards MS; Fuselier PA; Rench MA; Kasper DL; Baker CJ
Infect Immun; 1984 May; 44(2):257-61. PubMed ID: 6370863
[TBL] [Abstract][Full Text] [Related]
38. [Quantitation of IgG antibodies to type Ia group B streptococcal type-specific polysaccharides measured by enzyme-linked immunosorbent assay].
Sugiyama M; Kojima M; Yasuda Y; Hori Y; Nishiyama Y; Sugiyama A; Kido N; Ota M
Kansenshogaku Zasshi; 1990 Jul; 64(7):840-6. PubMed ID: 2230372
[TBL] [Abstract][Full Text] [Related]
39. [Type-specific antibody to type Ia, Ib, II and III group B Streptococcus in maternal and neonatal sera measured by ELISA].
Sugiyama M; Kojima M; Hori Y; Simizu S; Sugiyama A; Ooe Y; Nishiyama Y
Kansenshogaku Zasshi; 1990 Sep; 64(9):1232-8. PubMed ID: 2243195
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan.
Matsubara K; Katayama K; Baba K; Nigami H; Harigaya H
Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):453-4. PubMed ID: 12827529
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
